Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recombinant vaccine technology in veterinary medicine.

K R Van Kampen1

  • 1Van Kampen Group, Inc., Hoover, Alabama, USA.

The Veterinary Clinics of North America. Small Animal Practice
|July 12, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of a flue-curing process that reduces tobacco specific nitrosamines on the tumor promotion in SENCAR mice by cigarette smoke condensate.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association·2006
Same author

Comparative study of smoke condensates from 1R4F cigarettes that burn tobacco versus ECLIPSE cigarettes that primarily heat tobacco in the SENCAR mouse dermal tumor promotion assay.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association·2004
Same author

A responsive, sensitive, and reproducible dermal tumor promotion assay for the comparative evaluation of cigarette smoke condensates.

Regulatory toxicology and pharmacology : RTP·2004
Same author

Protection against tetanus by needle-free inoculation of adenovirus-vectored nasal and epicutaneous vaccines.

Journal of virology·2001
Same author

AdEasy system made easier by selecting the viral backbone plasmid preceding homologous recombination.

BioTechniques·2001
Same author

Immunotherapy and cytokines.

Seminars in veterinary medicine and surgery (small animal)·1997
Same journal

Practical Steps Toward Antimicrobial Stewardship for the General Practitioner.

The Veterinary clinics of North America. Small animal practice·2026
Same journal

Using Evidence-Based Veterinary Medicine and Artificial Intelligence to Support Clinical Decision Making in Veterinary Practice.

The Veterinary clinics of North America. Small animal practice·2026
Same journal

Feline Asthma-Update on Diagnosis and Treatment Recommendations.

The Veterinary clinics of North America. Small animal practice·2026
Same journal

Disease Prediction and Precision Veterinary Medicine: Applications, Opportunities, and Limitations of Artificial Intelligence in Small Animal Practice.

The Veterinary clinics of North America. Small animal practice·2026
Same journal

The Moving Target of Companion Animal Infectious Diseases: Emerging Threats and Evolving Solutions.

The Veterinary clinics of North America. Small animal practice·2026
Same journal

Challenging Gram-negative Infections: Perspectives from a Clinician and a Microbiologist.

The Veterinary clinics of North America. Small animal practice·2026
See all related articles

Recombinant vaccines offer a safe and effective new approach in veterinary medicine. These advanced vaccines provide enhanced stability and can protect animals against multiple diseases with a single dose.

Area of Science:

  • Veterinary Medicine
  • Vaccinology
  • Biotechnology

Background:

  • Recombinant technology represents a novel advancement in veterinary vaccine development.
  • Traditional vaccines sometimes pose risks or require adjuvants, which recombinant vaccines can avoid.

Purpose of the Study:

  • To highlight the advantages and applications of recombinant vaccines in veterinary medicine.
  • To showcase the potential for combination vaccines using recombinant platforms.

Main Methods:

  • Review of the principles and benefits of recombinant vaccine technology.
  • Compilation of currently licensed recombinant veterinary vaccines and their targets.

Main Results:

  • Recombinant vaccines offer improved safety, purity, potency, and efficacy.

Related Experiment Videos

  • Key benefits include pathogen avoidance, no need for adjuvants, and ambient temperature stability.
  • This technology enables the creation of multi-valent combination vaccines for animals.

    • Conclusions:

    • Recombinant vaccines are a significant innovation in animal health, offering superior characteristics.
    • The flexibility of recombinant technology facilitates the development of diverse and effective vaccines against various animal diseases.